Author:
Yu Jingyue,Hu Jinyu,Baldini Margaret,Lei Huan,Li Lei,Luo Shanshan,Wu Jielian,Liu Xupin,Shan Dan,Xie Yanfei,Fang Haihong,Yu Jun
Funder
Science and Technology Project of Jiangxi Provincial Department of Education
the Graduate Innovation Special Fund Project
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Luca AC, David SG, David AG, Țarcă V, Pădureț IA, Mîndru DE, Roșu ST, Roșu EV, Adumitrăchioaiei H, Bernic J, Cojocaru E, Țarcă E (2023) Atherosclerosis from Newborn to Adult-Epidemiology, Pathological Aspects, and Risk Factors. Life (Basel) 13:2056
2. Wolf MP, Hunziker P (2020) Atherosclerosis: Insights into Vascular Pathobiology and Outlook to Novel Treatments. Cardiovasc Transl Res 13:744–757
3. Frostegård J (2023) Antibodies against Phosphorylcholine-Implications for Chronic Inflammatory Diseases. Metabolites 13:720
4. Zahra H, Fatemeh S, Bahman R, Amirhossein S, Aria M, Hamed M (2018) NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. Cell Physiol 233:2116–2132
5. Xu W, Qian L, Yuan X, Lu Y (2022) MicroRNA-223-3p inhibits oxidized low-density lipoprotein-mediated NLRP3 inflammasome activation via directly targeting NLRP3 and FOXO3. Clin Hemorheol Microcirc 81:241–253